Benzinga
Benzinga
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Benzinga
lunedì, ottobre 19
Notizie dall’Italia
Azioni
Indici
Obbligazioni
ETF
Economia
Generale
Notizie USA
Azioni
Indici
Utili
Notizie Economiche
Mercati di previsione
Mercati privati
Altri Mercati
Dicono gli Analisti
Trading
Comunicati stampa
Notizie internazionali
Europa
Asia
Criptovalute
Notizie
Altcoin
Bitcoin
Blockchain
Dogecoin
Ethereum
Shiba Inu
NFT
Finanza personale
Investire in criptovalute
Investire in azioni
Forex
Ginkgo Bioworks Holdings Inc
DNA
NYSE
Watchlist
Get Report
Trade with Public
Get Report
Trade with Public
$10.07
-0.20
-1.95%
Ult. Agg.: Oct 19, 5:10 PM
$10.08
-0.19
-1.85%
Get Report
Panoramica
Notizie
Previsioni utili
Eventi
Obiettivi di prezzo
Dati finanziari
Sentiment
Azionariato
Confronta
Opzioni
Rapporto azionario
Privacy Manager
Ginkgo Bioworks Holdings Financials
Ginkgo Bioworks Holdings (DNA) financial statements — income, revenue, gross margin and key metrics.
Earnings & Guidance News
PRO
Ginkgo Bioworks Holdings Q1 EPS $(1.39) Misses $(1.34) Estimate, Sales $19.474M Miss $41.520M Estimate
Benzinga Newsdesk
Ginkgo Bioworks Pivots To AI And Robotics After Rough Quarter
Ginkgo Bioworks stock drops after earnings miss, lower sales, and shift to autonomous labs and robotics focus.
Vandana Singh
PRO
Ginkgo Bioworks Holdings Q4 EPS $(1.41) Misses $(1.36) Estimate, Sales $33.318M Miss $37.617M Estimate
Ginkgo Bioworks Holdings (NYSE:DNA) reported quarterly losses of $(1.41) per share which missed the analyst consensus estimate of $(1.36) by 3.68 percent. This is a 29.5 percent increase over losses of $(2.00) per share
Benzinga Newsdesk
Earnings Scheduled For February 26, 2026
Benzinga Insights
Insights into Ginkgo Bioworks Holdings's Upcoming Earnings
Benzinga Insights
Ginkgo Bioworks Stock Plummets Following Q3 Estimates Miss, Reaffirms FY2025 Outlook Below Consensus
Ginkgo Bioworks Holdings Inc (NYSE:DNA) shares are trading lower on Friday. The company released its third-quarter financial results.
Evette Mitkov
